Abstract
INTRODUCTION
Through the late 1980s, the vaccine market was beset by limited portfolios and
profitability. Recent technological breakthroughs in understanding disease
mechanisms, probably necessitated by pandemics and vaccine shortages, have
provided momentum for research in the past decade or so. This is apparent from
the increased research, patent, and regulatory activity in this area.
Breakthroughs in molecular biology, immunology, and computing promise a bright
future for the treatment of not only infectious diseases but also for
treatment of conditions such as chronic infections, cancer, autoimmune
diseases, allergies, and even nicotine addiction and high blood pressure using
vaccine technologies. Advances are also being made in almost all adjunct areas
of vaccine research, such as the mode of delivery, use of combination
vaccines, vaccine adjuvants, and vaccine manufacturing.
The market has also witnessed significant strategic alliance activity, changes
in centers of manufacture, and an increase in the importance of hitherto small
(such as adult vaccines) or nonexistent (therapeutic) segments.
Most of all, international health agencies have recognized the importance of
disease prevention and stupendous funding is being channelized into research,
purchase, and administration of vaccines.
SCOPE OF STUDY
This report contains:
- Descriptions of various human and veterinary vaccines that treat
infectious diseases, chronic infections, cancer, auto-immune diseases,
allergies, high blood pressure and addictions
- The current market status of the vaccine industry, with trends and
forecasts for growth over the next 5 years
- The latest vaccine research findings in prophylactic and therapeutic areas
- Analysis of significant vaccine-related patents in the Unites States and
Europe
- An overview of the regulatory environment.
INFORMATION SOURCES
Data were compiled from industry experts and other stakeholders as well as
various secondary sources such as government, nongovernment industry
stakeholders, technology and market publications, and other public research
data sources.
| 
View Cart
